Skip to main content

Home  About Us  Services  News&Events  Contact Us  Careers   
Collaboration is key...

Exquiron is a recently founded company dedicated to contract research in early stage drug discovery. Our services span from assay development and adaptation for hit finding and profiling purposes to compound selection, high throughput screening, selectivity testing and hit characterization, and SAR expansion.
Collaboration is key, thus, our scientists will work with you to identify the most suitable workflow to add value and advance your project.
Our team brings proven expertise to all areas of the hit identification process, including broad target class coverage, assay systems and technologies, data processing, evaluation, quality control and reporting.

… we want to be your partner for drug discovery.

Visit our Services page to get a glimpse of the breadth of our offerings, to get an overview of our fresh compound collection, and to see the state-of-the-art technologies we employ.
Please contact us to discuss your needs, send an inquiry, or to learn more about our services.
Check our site regularly for updates and news. Click here to sign up for our quarterly newsletter.



Come and meet us at the following conference:
SLAS 2015, Washington DC, USA, 7th-11th February '15. booth #1447
Latest news
June 3, 2013
Exquiron Biotech AG
Kägenstrasse 17
4153 Reinach (BL)
T: +41 61 716 85 85